• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢交界性肿瘤患者卵巢中存在小肿瘤起始干细胞的新群体。

Novel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancer.

机构信息

Department of Obstetrics and Gynaecology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.

出版信息

Sci Rep. 2016 Oct 5;6:34730. doi: 10.1038/srep34730.

DOI:10.1038/srep34730
PMID:27703207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5050448/
Abstract

Small stem cells with diameters of up to 5 μm previously isolated from adult human ovaries indicated pluripotency and germinal lineage, especially primordial germ cells, and developed into primitive oocyte-like cells in vitro. Here, we show that a comparable population of small stem cells can be found in the ovarian tissue of women with borderline ovarian cancer, which, in contrast to small stem cells in "healthy" ovaries, formed spontaneous tumour-like structures and expressed some markers related to pluripotency and germinal lineage. The gene expression profile of these small putative cancer stem cells differed from similar cells sorted from "healthy" ovaries by 132 upregulated and 97 downregulated genes, including some important forkhead box and homeobox genes related to transcription regulation, developmental processes, embryogenesis, and ovarian cancer. These putative cancer stem cells are suggested to be a novel population of ovarian tumour-initiating cells in humans.

摘要

先前从成人卵巢中分离出的直径达 5μm 的小干细胞表现出多能性和生殖系,特别是原始生殖细胞,并在体外发育成原始卵母细胞样细胞。在这里,我们表明,在患有交界性卵巢癌的女性的卵巢组织中可以找到类似的小干细胞群,与“健康”卵巢中的小干细胞不同,这些小干细胞自发形成肿瘤样结构,并表达一些与多能性和生殖系相关的标记物。这些小的拟似癌干细胞的基因表达谱与从“健康”卵巢中分离出的类似细胞有 132 个上调和 97 个下调基因的差异,包括一些与转录调控、发育过程、胚胎发生和卵巢癌相关的重要叉头框和同源盒基因。这些拟似癌干细胞被认为是人类卵巢肿瘤起始细胞的一个新群体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/24c2de46dc31/srep34730-f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/a674d30ce809/srep34730-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/8e1bd58dd623/srep34730-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/127235d3f057/srep34730-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/2837abde52d3/srep34730-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/7184ebc74007/srep34730-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/f41c52419285/srep34730-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/dcbac8ebe3e1/srep34730-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/16ac9a2a51cd/srep34730-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/b41be5ac3274/srep34730-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/f2cee587a4eb/srep34730-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/24c2de46dc31/srep34730-f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/a674d30ce809/srep34730-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/8e1bd58dd623/srep34730-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/127235d3f057/srep34730-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/2837abde52d3/srep34730-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/7184ebc74007/srep34730-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/f41c52419285/srep34730-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/dcbac8ebe3e1/srep34730-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/16ac9a2a51cd/srep34730-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/b41be5ac3274/srep34730-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/f2cee587a4eb/srep34730-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/5050448/24c2de46dc31/srep34730-f11.jpg

相似文献

1
Novel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancer.卵巢交界性肿瘤患者卵巢中存在小肿瘤起始干细胞的新群体。
Sci Rep. 2016 Oct 5;6:34730. doi: 10.1038/srep34730.
2
Small putative NANOG, SOX2, and SSEA-4-positive stem cells resembling very small embryonic-like stem cells in sections of ovarian tissue in patients with ovarian cancer.在卵巢癌患者的卵巢组织切片中,存在类似极小胚胎样干细胞的假定NANOG、SOX2和SSEA - 4阳性小干细胞。
J Ovarian Res. 2016 Mar 3;9:12. doi: 10.1186/s13048-016-0221-3.
3
Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers.运用波形蛋白和多能性相关标志物的免疫组织化学方法,在浆液性卵巢癌患者的卵巢肿瘤切片中揭示了假定的干细胞和上皮-间质转化。
J Ovarian Res. 2017 Feb 23;10(1):11. doi: 10.1186/s13048-017-0306-7.
4
Similar Population of CD133+ and DDX4+ VSEL-Like Stem Cells Sorted from Human Embryonic Stem Cell, Ovarian, and Ovarian Cancer Ascites Cell Cultures: The Real Embryonic Stem Cells?从人胚胎干细胞、卵巢和卵巢癌腹水中分选的 CD133+ 和 DDX4+ VSEL 样干细胞具有相似的群体:真正的胚胎干细胞?
Cells. 2019 Jul 11;8(7):706. doi: 10.3390/cells8070706.
5
Small SSEA-4-positive cells from human ovarian cell cultures: related to embryonic stem cells and germinal lineage?人类卵巢细胞培养中的小 SSEA-4 阳性细胞:与胚胎干细胞和生殖系有关?
J Ovarian Res. 2013 Apr 9;6:24. doi: 10.1186/1757-2215-6-24. eCollection 2013.
6
Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers.卵巢无性细胞瘤的特征是频繁的KIT基因突变和多能性标志物的大量表达。
Mol Cancer. 2007 Feb 2;6:12. doi: 10.1186/1476-4598-6-12.
7
Ovarian Cancer Stem Cells: Unraveling a Germline Connection.卵巢癌干细胞:揭开种系联系。
Stem Cells Dev. 2017 Dec 15;26(24):1781-1803. doi: 10.1089/scd.2017.0153. Epub 2017 Nov 28.
8
Isolation of small SSEA-4-positive putative stem cells from the ovarian surface epithelium of adult human ovaries by two different methods.通过两种不同方法从小鼠卵巢表面上皮中分离出小的 SSEA-4 阳性拟干细胞。
Biomed Res Int. 2013;2013:690415. doi: 10.1155/2013/690415. Epub 2013 Feb 18.
9
The significance of the pluripotency and cancer stem cell-related marker NANOG in diagnosis and treatment of ovarian carcinoma.多能性及癌症干细胞相关标志物NANOG在卵巢癌诊断与治疗中的意义
Eur J Gynaecol Oncol. 2016;37(5):604-612.
10
Functional Testing of Primitive Oocyte-like Cells Developed in Ovarian Surface Epithelium Cell Culture from Small VSEL-like Stem Cells: Can They Be Fertilized One Day?从小 VSEL 样干细胞来源的卵巢表面上皮细胞培养中发育的原始卵母细胞样细胞的功能测试:它们有一天能受精吗?
Stem Cell Rev Rep. 2018 Oct;14(5):715-721. doi: 10.1007/s12015-018-9832-y.

引用本文的文献

1
Selected stem cell populations in pediatric acute lymphoblastic leukemia.小儿急性淋巴细胞白血病中的特定干细胞群体。
Front Immunol. 2024 Sep 25;15:1446687. doi: 10.3389/fimmu.2024.1446687. eCollection 2024.
2
Affinity-Based Magnetic Nanoparticle Development for Cancer Stem Cell Isolation.基于亲和力的磁性纳米颗粒用于癌症干细胞分离的研究进展
Polymers (Basel). 2024 Jan 9;16(2):196. doi: 10.3390/polym16020196.
3
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy.探索诱导多能干细胞在癌症研究和治疗中的广阔前景。

本文引用的文献

1
RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA.高级别浆液性卵巢癌中RASSF1A启动子甲基化:原发性肿瘤、形态学上相邻无肿瘤细胞组织及配对循环肿瘤DNA的直接比较研究
Oncotarget. 2017 Mar 28;8(13):21429-21443. doi: 10.18632/oncotarget.15249.
2
Antibiotic monensin synergizes with EGFR inhibitors and oxaliplatin to suppress the proliferation of human ovarian cancer cells.抗生素莫能菌素与表皮生长因子受体(EGFR)抑制剂及奥沙利铂协同作用,以抑制人卵巢癌细胞的增殖。
Sci Rep. 2015 Dec 7;5:17523. doi: 10.1038/srep17523.
3
Mol Cancer. 2023 Nov 28;22(1):189. doi: 10.1186/s12943-023-01873-0.
4
Cellular enlargement - A new hallmark of aging?细胞增大——衰老的一个新标志?
Front Cell Dev Biol. 2022 Nov 10;10:1036602. doi: 10.3389/fcell.2022.1036602. eCollection 2022.
5
Short histological kaleidoscope - recent findings in histology. Part I.组织学短景 - 组织学的新发现。第一部分。
Rom J Morphol Embryol. 2022 Jan-Mar;63(1):7-29. doi: 10.47162/RJME.63.1.01.
6
Dysfunctional Ovarian Stem Cells Due to Neonatal Endocrine Disruption Result in PCOS and Ovarian Insufficiency in Adult Mice.由于新生儿内分泌干扰导致的卵巢干细胞功能障碍导致成年小鼠出现 PCOS 和卵巢功能不全。
Stem Cell Rev Rep. 2022 Dec;18(8):2912-2927. doi: 10.1007/s12015-022-10414-z. Epub 2022 Jul 14.
7
Cancer Initiates Due to Excessive Self-Renewal and Blocked Differentiation of Tissue-Resident, OCT-4 Positive VSELs.癌症是由于组织驻留的、OCT-4阳性的非常小胚胎样干细胞过度自我更新和分化受阻而引发的。
Stem Cell Rev Rep. 2022 Dec;18(8):3112-3114. doi: 10.1007/s12015-022-10424-x. Epub 2022 Jul 12.
8
Aged mice ovaries harbor stem cells and germ cell nests but fail to form follicles.老年小鼠的卵巢中存在干细胞和生殖细胞巢,但无法形成卵泡。
J Ovarian Res. 2022 Mar 23;15(1):37. doi: 10.1186/s13048-022-00968-4.
9
Cell size is a determinant of stem cell potential during aging.细胞大小是衰老过程中干细胞潜能的一个决定因素。
Sci Adv. 2021 Nov 12;7(46):eabk0271. doi: 10.1126/sciadv.abk0271.
10
Endogenous, tissue-resident stem/progenitor cells in gonads and bone marrow express FSHR and respond to FSH via FSHR-3.睾丸和骨髓中的内源性组织驻留干细胞/祖细胞表达 FSHR,并通过 FSHR-3 对 FSH 作出反应。
J Ovarian Res. 2021 Oct 30;14(1):145. doi: 10.1186/s13048-021-00883-0.
Ovarian cancer: beyond resistance.
卵巢癌:超越耐药性。
Nature. 2015 Nov 26;527(7579):S217. doi: 10.1038/527S217a.
4
A Systematic Review of Symptoms for the Diagnosis of Ovarian Cancer.卵巢癌诊断症状的系统评价
Am J Prev Med. 2016 Mar;50(3):384-394. doi: 10.1016/j.amepre.2015.09.023. Epub 2015 Nov 2.
5
The Role of CA 125 as Tumor Marker: Biochemical and Clinical Aspects.CA 125作为肿瘤标志物的作用:生化及临床方面
Adv Exp Med Biol. 2015;867:229-44. doi: 10.1007/978-94-017-7215-0_14.
6
The Factors Predicting Recurrence in Patients With Serous Borderline Ovarian Tumor.浆液性卵巢交界性肿瘤患者复发的预测因素
Int J Gynecol Cancer. 2016 Jan;26(1):66-72. doi: 10.1097/IGC.0000000000000568.
7
Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes.低级别浆液性卵巢肿瘤的分子图谱分析鉴定出新型候选驱动基因。
Oncotarget. 2015 Nov 10;6(35):37663-77. doi: 10.18632/oncotarget.5438.
8
Ovarian serous borderline tumors with noninvasive and invasive peritoneal implants: A case report each.伴有非侵袭性和侵袭性腹膜种植的卵巢浆液性交界性肿瘤:各1例病例报告。
J Cancer Res Ther. 2015 Jul-Sep;11(3):646. doi: 10.4103/0973-1482.147707.
9
New Pointers for Surgical Staging of Borderline Ovarian Tumors.卵巢交界性肿瘤手术分期的新指南
Ann Surg Oncol. 2016 Feb;23(2):443-9. doi: 10.1245/s10434-015-4784-9. Epub 2015 Aug 5.
10
Genetic changes correlate with histopathology in a benign, borderline and malignant mucinous ovarian tumour.基因变化与良性、交界性和恶性黏液性卵巢肿瘤的组织病理学相关。
J Obstet Gynaecol. 2016;36(1):119-21. doi: 10.3109/01443615.2015.1036406. Epub 2015 Oct 6.